Julie Khlevner, MD, AGAF

Julie Khlevner, MD, AGAFAssociate Professor of Pediatrics at Columbia University Medical CenterChair, NASPGHAN Neurogastroenterology and Motility Committee.

Articles by Julie Khlevner, MD, AGAF

FDA Expansion of Linaclotide for Children 2-5 Years With Functional Constipation

ByJulie Khlevner, MD, AGAF

June 3rd 2026

Khlevner, MD, discusses the expanded FDA approval of linaclotide for children aged ≥2 years with functional constipation.

Julie Khlevner, MD, AGAF, Reacts to the FDA Approval of Linaclotide for Pediatric IBS-C

ByJulie Khlevner, MD, AGAF

November 6th 2025

Julie Khlevner, MD, AGAF, highlights that FDA approval of linaclotide provides the first pharmacologic therapy for pediatric IBS-C.

Julie Khlevner, MD, AGAF

Articles by Julie Khlevner, MD, AGAF

FDA Expansion of Linaclotide for Children 2-5 Years With Functional Constipation

Julie Khlevner, MD, AGAF, Reacts to the FDA Approval of Linaclotide for Pediatric IBS-C

Latest Updated Articles

Trending on HCPLive

TRIUMPH-1: Retatrutide Substantially Lowers Weight, BMI in Patients With Obesity or Overweight

Machine Learning Model Predicts Type 2 Diabetes Risk Up To 10 Years Out

TRANSCEND-T2D-1: Retatrutide Demonstrates Superior Weight Loss and A1c Results Versus Placebo

ACCESS: Aleniglipron Achieves Up To 11.3% Weight Loss in Phase 2b Obesity Trial

5 Hepatology Headlines You Missed in May 2026